You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CTCL

Showing 26 - 50 of 175
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cutaneous T-Cell Lymphoma Trial in Worldwide (IPH4102)

Completed
  • Cutaneous T-Cell Lymphoma
  • IPH4102
  • Stanford, California
  • +4 more
Jan 19, 2021

T-Cell Lymphoma Relapsed, Adult T-Cell Leukemia (ATL), Peripheral T-Cell Lymphoma (PTCL) Trial run by the NCI (IL-15 plus,

Completed
Has Results
  • T-Cell Lymphoma Relapsed
  • +4 more
  • IL-15 plus
  • alemtuzumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 27, 2022

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Sézary Syndrome Trial in United States (Naloxone Hydrochloride Lotion, 0.5%,

Terminated
  • Mycosis Fungoides
  • +2 more
  • Naloxone Hydrochloride Lotion, 0.5%
  • Placebo Lotion
  • Little Rock, Arkansas
  • +15 more
Oct 26, 2022

Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Australia, Singapore (Selinexor)

Terminated
Has Results
  • Peripheral T-cell Lymphoma (PTCL)
  • Cutaneous T-cell Lymphoma (CTCL)
  • Concord, New South Wales, Australia
  • +4 more
Sep 8, 2020

Lymphoma, Disorder Related to Bone Marrow Transplantation Trial in Houston (Fludarabine, Melphalan, Allogeneic Transplant)

Completed
Has Results
  • Lymphoma
  • Disorder Related to Bone Marrow Transplantation
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 3, 2020

Follicular Lymphoma (FL/Indolent NHL), Aggressive NHL (a NHL), Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma

Completed
Has Results
  • Follicular Lymphoma (FL/Indolent NHL)
  • +4 more
  • Huntsville, Alabama
  • +22 more
Apr 1, 2022

Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • +2 more
    • Ancona, Italy
    • +19 more
    Nov 2, 2023

    Cutaneous T Cell Lymphoma Trial in Chicago (APR-TD011 (RLF-TD011))

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • APR-TD011 (RLF-TD011)
    • Chicago, Illinois
      Dermatology CTU
    Feb 6, 2023

    Cutaneous T-Cell Lymphoma Trial in United States (Panobinostat)

    Terminated
    Has Results
    • Cutaneous T-Cell Lymphoma
    • Birmingham, Alabama
    • +17 more
    Aug 16, 2021

    Lymphoma Trial in Los Angeles (bortezomib)

    Completed
    Has Results
    • Lymphoma
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center at UCLA
    Jul 30, 2020

    Cutaneous T-Cell Lymphoma Trial in Worldwide (KW-0761, Vorinostat)

    Completed
    Has Results
    • Cutaneous T-Cell Lymphoma
    • Birmingham, Alabama
    • +72 more
    Jul 22, 2022

    Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Belgium, France, United States (Cobomarsen)

    Terminated
    • Cutaneous T-Cell Lymphoma/Mycosis Fungoides
    • Phoenix, Arizona
    • +8 more
    Nov 17, 2020

    T-Cell Lymphoma, Peripheral T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma Refractory Trial in United States (LB1901)

    Active, not recruiting
    • T-Cell Lymphoma
    • +4 more
    • LB1901
    • Rochester, Minnesota
    • +3 more
    Feb 15, 2022

    T Cell Lymphoma Trial in New Haven (Mogamulizumab, DA-EPOCH Protocol)

    Not yet recruiting
    • T Cell Lymphoma
    • New Haven, Connecticut
      Yale Smilow Cancer Hospital
    Aug 14, 2023

    Cutaneous T Cell Lymphoma Trial in Mannheim (dimethylfumarate)

    Unknown status
    • Cutaneous T Cell Lymphoma
    • Mannheim, Germany
      University Medical Center
    Sep 30, 2019

    Lymphoma, T-Cell, Cutaneous Trial in Bronx (Doxycycline, Imiquimod)

    Unknown status
    • Lymphoma, T-Cell, Cutaneous
    • Bronx, New York
      James J Peters Bronx Veterans Affairs Medical Center
    Aug 12, 2019

    Mycosis Fungoides, Sezary Syndrome, Mycosis Fungoides/Sezary Syndrome Trial in Saint Louis (Tulmimetostat)

    Not yet recruiting
    • Mycosis Fungoides
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jul 13, 2023

    Advanced Malignancies Trial in Denmark, Hungary, Russian Federation (BI-1808, Pembrolizumab 25 Mg/mL Solution for Injection)

    Recruiting
    • Advanced Malignancies
    • BI-1808
    • Pembrolizumab 25 Mg/mL Solution for Injection
    • Copenhagen, Denmark
    • +11 more
    Sep 9, 2022

    Mycosis Fungoides of Skin (Diagnosis), Cutaneous T-cell Lymphoma, Non Hodgkin Lymphoma Trial in Cleveland (Med-Jet Injector,

    Not yet recruiting
    • Mycosis Fungoides of Skin (Diagnosis)
    • +5 more
    • Med-Jet Injector
    • +4 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jan 17, 2023

    T-cell Lymphoma, Relapsed and Refractory T-cell Lymphoma Trial in New York, Columbus (Ibrutinib)

    Active, not recruiting
    • T-cell Lymphoma
    • Relapsed and Refractory T-cell Lymphoma
    • New York, New York
    • +1 more
    Nov 8, 2022

    Persistent or Recurrent Cutaneous T-Cell Lymphoma Trial in Australia, Puerto Rico, United States (E7777 9 mcg/kg)

    Completed
    • Persistent or Recurrent Cutaneous T-Cell Lymphoma
    • E7777 9 mcg/kg
    • Birmingham, Alabama
    • +21 more
    Dec 5, 2022

    Advanced Solid Tumor, Cutaneous T Cell Lymphoma Trial in Guanzhou (SIM1811-03)

    Recruiting
    • Advanced Solid Tumor
    • Cutaneous T Cell Lymphoma
    • Guanzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Mar 10, 2023

    Cutaneous T-cell Lymphoma (CTCL), Mycosis Fungoides (MF), Chronic Lymphocytic Leukemia (CLL) Trial in United States (Cobomarsen)

    Completed
    • Cutaneous T-cell Lymphoma (CTCL)
    • +4 more
    • Duarte, California
    • +18 more
    Nov 19, 2020

    T-Cell Tumor, Lymphoproliferative Disorders Trial in Ann Arbor (Pacritinib)

    Not yet recruiting
    • T-Cell Neoplasm
    • Lymphoproliferative Disorders
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Oct 6, 2022

    T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma Trial in Chicago (Fenretinide)

    Not yet recruiting
    • T-cell Lymphoma
    • +10 more
    • Chicago, Illinois
      Rush University Medical Center
    Oct 24, 2022